Motoyuki Tamaki
Overview
Explore the profile of Motoyuki Tamaki including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
27
Citations
411
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Tamaki M, Inagaki T, Minato M, Shibata E, Nishioka R, Nishioka S, et al.
Intern Med
. 2024 Oct;
PMID: 39370259
Objective Roxadustat, a hypoxia-inducible factor-prolyl hydroxylase inhibitor, increases the hemoglobin (Hb) levels in patients with chronic kidney disease (CKD). To date, limited clinical studies have focused on the excessive increase...
2.
Mori H, Taniguchi S, Tamaki Y, Tamaki M, Akehi Y, Kuroda A, et al.
Nutrients
. 2024 Jan;
16(2).
PMID: 38257162
This study examined the non-inferior efficacy of telenutrition education compared with face-to-face nutrition education in managing glycemic control in people with type 2 diabetes mellitus (T2DM). Participants had T2DM and...
3.
Otoda T, Sekine A, Uemoto R, Tsuji S, Hara T, Tamaki M, et al.
Diabetes Ther
. 2023 Oct;
15(1):127-143.
PMID: 37883001
Introduction: Large-scale clinical trials of sodium-glucose cotransporter 2 inhibitors (SGLT2i) demonstrate proteinuria-reducing effects in diabetic kidney disease, even after treatment with renin-angiotensin inhibitors. The precise mechanism for this favorable effect...
4.
Okada A, Yamada-Yamashita M, Tominaga Y, Jo K, Mori H, Suzuki R, et al.
J Diabetes Investig
. 2022 Apr;
13(7):1140-1148.
PMID: 35396829
Aims/introduction: Several research groups have reported methods for quantifying pancreatic beta cell (β-cell) injury by measuring β-cell-specific CpG unmethylation of the insulin gene in circulation using digital droplet PCR or...
5.
Fukaishi T, Nakagawa Y, Fukunaka A, Sato T, Hara A, Nakao K, et al.
Diabetologia
. 2021 Sep;
64(12):2803-2816.
PMID: 34498099
Aims/hypothesis: Pancreatic polypeptide (PP) cells, which secrete PP (encoded by the Ppy gene), are a minor population of pancreatic endocrine cells. Although it has been reported that the loss of...
6.
Hara A, Nakagawa Y, Nakao K, Tamaki M, Ikemoto T, Shimada M, et al.
Endocr J
. 2019 Mar;
66(5):459-468.
PMID: 30842364
Pancreatic polypeptide (PP) is a 36-amino acid peptide encoded by the Ppy gene, which is produced by a small population of cells located in the periphery of the islets of...
7.
Mori H, Kuroda A, Ishizu M, Ohishi M, Takashi Y, Otsuka Y, et al.
J Diabetes Investig
. 2019 Jan;
10(5):1332-1340.
PMID: 30677242
Aims/introduction: Advanced glycation end-products (AGEs), which are a major cause of diabetic vascular complications, accumulate in various tissues under chronic hyperglycemic conditions, as well as with aging in patients with...
8.
Kuroda A, Tsuruo M, Aki N, Kondo T, Oguro Y, Tamaki M, et al.
Diabetol Int
. 2019 Jan;
8(1):112-115.
PMID: 30603314
Aims: To compare the diurnal glycemic profiles obtained with basal insulin degludec (InsDeg) and basal insulin glargine (InsGla) in patients with type 1 diabetes using continuous glucose monitoring (CGM) in...
9.
Miyagi M, Uchino H, Kumashiro N, Higa M, Shin K, Sasamoto M, et al.
Diabetes Ther
. 2018 Aug;
9(5):1959-1968.
PMID: 30121725
Introduction: It is unclear whether adding basal insulin or enhancing incretin signaling with a glucagon-like peptide-1 receptor agonist (GLP-1RA) is more effective as an up-titration strategy after dipeptidyl peptidase-4 inhibitor...
10.
Kuroda A, Taniguchi S, Akehi Y, Mori H, Tamaki M, Suzuki R, et al.
J Diabetes Sci Technol
. 2017 Oct;
11(6):1096-1100.
PMID: 28992720
Background: Glucose values of continuous glucose monitoring (CGM) have time delays compared with plasma glucose (PG) values. The artificial pancreas (STG-55, Nikkiso, Japan) (AP), which measures venous blood glucose directly,...